We are live on ! Find out more
SIC

Salem Investment Counselors Portfolio holdings

AUM $4.03B
1-Year Est. Return 61.49%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+61.49%
3 Year Est. Return
+158.64%
5 Year Est. Return
+203.54%
10 Year Est. Return
+1,118.52%
AUM
$3.16B
AUM Growth
+$284M
Cap. Flow
+$2.35M
Cap. Flow %
0.07%
Top 10 Hldgs %
48.09%
Holding
1,277
New
57
Increased
182
Reduced
303
Closed
105

Top Buys

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$13.9M
2
ETN icon
Eaton
ETN
+$6.78M
3
COF icon
Capital One
COF
+$5.85M
4
CRI icon
Carter's
CRI
+$3.13M
5
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.06M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$14.4M
2
UNH icon
UnitedHealth
UNH
+$7.63M
3
DFS
Discover Financial Services
DFS
+$5.3M
4
MRK icon
Merck
MRK
+$5.06M
5
NVDA icon
NVIDIA
NVDA
+$3.01M

Sector Composition

Rank Sector Weight
1 Technology 31.29%
2 Consumer Discretionary 18.22%
3 Financials 11.13%
4 Healthcare 8.68%
5 Communication Services 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VT icon
726
Vanguard Total World Stock ETF
VT
$81.9B
$19.3K ﹤0.01%
150
CBRE icon
727
CBRE Group
CBRE
$44B
$19.2K ﹤0.01%
137
BALL icon
728
Ball Corp
BALL
$16.4B
$19.1K ﹤0.01%
340
-150
-31% -$7.83K
IWS icon
729
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
$19K ﹤0.01%
144
ADSK icon
730
Autodesk
ADSK
$54.5B
$18.9K ﹤0.01%
61
-9
-13% -$2.55K
CNXC icon
731
Concentrix
CNXC
$1.52B
$18.9K ﹤0.01%
357
KEY icon
732
KeyCorp
KEY
$24.6B
$18.8K ﹤0.01%
1,082
NTLA icon
733
Intellia Therapeutics
NTLA
$1.66B
$18.8K ﹤0.01%
2,000
CPZ
734
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$269M
$18.7K ﹤0.01%
1,150
TNDM icon
735
Tandem Diabetes Care
TNDM
$1.61B
$18.6K ﹤0.01%
1,000
UBSI icon
736
United Bankshares
UBSI
$6.68B
$18.4K ﹤0.01%
501
AB icon
737
AllianceBernstein
AB
$3.41B
$18.4K ﹤0.01%
450
MBB icon
738
iShares MBS ETF
MBB
$39.2B
$18.3K ﹤0.01%
195
-1
-0.5% -$93
BKR icon
739
Baker Hughes
BKR
$63B
$18.2K ﹤0.01%
474
+420
+778% +$15.8K
SCZ icon
740
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.6B
$18.2K ﹤0.01%
250
SHY icon
741
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$18.1K ﹤0.01%
218
VEU icon
742
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
$18K ﹤0.01%
268
-2,000
-88% -$127K
NMCO icon
743
Nuveen Municipal Credit Opportunities Fund
NMCO
$589M
$18K ﹤0.01%
1,665
EEMV icon
744
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
$18K ﹤0.01%
286
KLAC icon
745
KLA
KLAC
$274B
$17.9K ﹤0.01%
200
IGF icon
746
iShares Global Infrastructure ETF
IGF
$10.7B
$17.8K ﹤0.01%
300
NTRS icon
747
Northern Trust
NTRS
$34.8B
$17.7K ﹤0.01%
139
DAL icon
748
Delta Air Lines
DAL
$60B
$17.6K ﹤0.01%
357
SNY icon
749
Sanofi
SNY
$105B
$17.5K ﹤0.01%
362
-62
-15% -$3.17K
UVV icon
750
Universal Corp
UVV
$1.12B
$17.5K ﹤0.01%
300

Similar funds

Salem Investment Counselors's Q2 2025 Portfolio in Review

As of Q2 2025, Salem Investment Counselors held 1,277 positions worth $3.16B, up 9.9% from $2.87B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Salem Investment Counselors's Q2 2025 filing shows 57 new, 182 increased, 303 reduced and 105 closed positions. Its largest new stake was Astera Labs: 175,844 shares worth $15.9M. The largest sale was Palantir, an estimated $14.4M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Salem Investment Counselors's largest Q2 2025 buy was Astera Labs: 175,844 shares worth $15.9M.
  • Salem Investment Counselors added most to Eaton in Q2 2025, an estimated $6.78M increase.
  • Salem Investment Counselors's biggest Q2 2025 reduction was Palantir, cutting an estimated $14.4M.
  • Salem Investment Counselors fully exited Discover Financial Services in Q2 2025, selling an estimated $5.3M.
  • Salem Investment Counselors's ten largest holdings make up 48% of its $3.16B portfolio in Q2 2025.
  • Salem Investment Counselors opened 57 new positions and closed 105 in Q2 2025.
  • Salem Investment Counselors's portfolio value rose 9.9% quarter-over-quarter to $3.16B.

Based on Salem Investment Counselors's 13F filing for Q2 2025, filed 7 Jul 2025.